1 min read
PangeaMT – Start planning your MT adoption for success! Aligning the paper title with that of this year’s ATC Conference, “Evolution of the...
As many of you will know, it was a particularly successful year for the industry. We have seen a truly stellar performance from the R & D communities with a record of 46 FDA approvals in 2017!! If that wasn’t impressive enough, there are more products in development than any
other time in history – with 15K products in the pipeline! It is a good time to be alive, some even going as far as calling it the “golden age” of pharma innovation. That being said, innovation goes further than just new therapies, and we have seen huge leaps in terms of process improvements and among others we can mention advances in chemistry, 3D printers and of course AI -
an area where Pangeanic is seeing fantastic results. All this is, of course, reducing costs and increasing patient access abilities. It was reported that CPhI Madrid welcomed over 45K attendees with over 2500 exhibitors! That is all very impressive but what really matters to us are the relationships that were nurtured at CPhI with our usual clients, not to mention the opportunity to establish exciting new partnerships.
1 min read
2 min read
2 min read